Verastem, Inc. (VSTM) Financial Statements
Verastem, Inc. (VSTM) reported trailing twelve-month revenue of $87.5M (up 3995.7% year on year) and net income of -$202.7M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$162.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 909.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26. Results for the next quarter were released 14 Oct; these figures move once the 10-Q is filed.
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26.7 | 17.5 | 88.5 | 2.1 | 2.6 | 10.0 | 30.9 | 87.5 | |
| Gross profit | 26.6 | — | — | — | — | — | 25.6 | — | |
| Research & development | 43.6 | 45.8 | 41.4 | 39.3 | 50.6 | 81.3 | 114.6 | 140.2 | |
| Operating income | -94.8 | -132.3 | -49.4 | -61.4 | -72.9 | -115.0 | -170.1 | -159.8 | |
| Pre-tax income | -72.4 | -149.2 | -67.5 | -71.2 | -73.8 | -130.5 | -209.5 | -201.9 | |
| Income tax | — | — | 0.2 | 0.0 | 0.0 | 0.2 | — | — | |
| Net income | -72.4 | -149.2 | -67.7 | -71.2 | -73.8 | -130.6 | -209.5 | -202.7 | |
| Diluted EPS ($) | -1.37 | -2.00 | -0.44 | -4.90 | -4.57 | -3.66 | -3.02 | -2.12 | |
| Diluted shares (mn) | 69.3 | 74.6 | 153.3 | 14.5 | 16.1 | 35.7 | 69.3 | — |
USD millions · SEC XBRL
Verastem, Inc. — questions
- What is Verastem, Inc.'s revenue?
- $87.5M over the twelve months to 2026-06-30, up 3995.7% year on year, from its 10-Q and 10-K filings.
- What is Verastem, Inc.'s net income?
- -$202.7M over the twelve months to 2026-06-30.
- What is Verastem, Inc.'s free cash flow?
- -$162.2M over the twelve months to 2026-06-30.
- What are Verastem, Inc.'s diluted earnings per share?
- $-2.12 over the twelve months to 2026-06-30.
Every figure on this page comes from Verastem, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.